Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • F.L.
    Junior Member
    • Jul 2015
    • 1

    Methyl-Seq: Lib prep (MspI;HpaII) for mouse samples causes issues for human samples

    Hello,

    I have a question concerning whole genome enzymatic digestion in preparation for NGS. Currently, we digest mouse tissue and cell line samples, using the standard enzymes MspI and HpaII, as an intermediary step before the actual NGS. The procedure works fine, yet when we wanted to use the same technique on samples of human origin (cell line, tissue or blood), the digestion seems to fail. We are using the same enzyme and buffer batch as for the mouse samples. Yet we do not find back digested fragments for the human samples when doing a size-selection gel, contrary to the digested fragments of the mouse samples that are present. Running the mouse and human samples in parallel, checking the possible interference of reagents used during DNA extraction did not change anything. The conditions of the digestion are the same for both samples, in silico digestion of both genomes seemed fine, and according to literature these enzymes should work for both genomes. Does anyone have any experience/encountered similar problems or has an idea what could be the problem when we shift from mouse to human samples? Thanks for your help!

    Kind Regards
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    That does not make sense. If you can post an image or electropherogram of sample before or better a mock digest (no enzyme) and after digest someone might be able to help.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM
    • GATTACAT
      Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
      by GATTACAT
      Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
      07-01-2026, 11:43 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-07-2026, 11:05 AM
    0 responses
    34 views
    0 reactions
    Last Post SEQadmin2  
    Working...